問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Taichung Veterans General Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2024-06-30 - 2029-06-30
Condition/Disease
Test Drug
Participate Sites8Sites
Recruiting8Sites
2020-06-01 - 2024-04-30
patients with inoperable cholangiocarcinoma (CCA)
Amphinex
Participate Sites3Sites
Recruiting3Sites
2021-11-01 - 2025-12-31
Participate Sites6Sites
Recruiting6Sites
2023-12-01 - 2029-04-30
Participate Sites9Sites
Recruiting9Sites
2020-04-01 - 2032-06-30
relapsed/refractory follicular lymphoma
Tazemetostat
Participate Sites5Sites
Not yet recruiting1Sites
Recruiting4Sites
2024-12-02 - 2030-12-09
Participate Sites2Sites
Recruiting2Sites
2024-04-12 - 2028-12-31
Moderately to Severely Active Ulcerative Colitis
GS-1427
2022-11-15 - 2034-07-12
xxxxxx
AlectinibEntrectinibEntrectinibPralsetinibDurvalumab
2023-05-10 - 2025-04-30
SerpinPCSterile Water for Injection 10mL vial
2024-09-01 - 2026-12-31
amlitelimab
全部
